Biological drivers of clinical phenotype in myelofibrosis

Myelofibrosis (MF) is a myeloproliferative disorder that exhibits considerable biological and clinical heterogeneity. At the two ends of the disease spectrum are the myelodepletive or cytopenic phenotype and the myeloproliferative phenotype. The cytopenic phenotype has a high prevalence in primary M...

Descripción completa

Detalles Bibliográficos
Autores principales: Mascarenhas, John, Gleitz, Hélène F. E., Chifotides, Helen T., Harrison, Claire N., Verstovsek, Srdan, Vannucchi, Alessandro Maria, Rampal, Raajit K., Kiladjian, Jean-Jacques, Vainchenker, William, Hoffman, Ronald, Schneider, Rebekka K., List, Alan F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9898039/
https://www.ncbi.nlm.nih.gov/pubmed/36434065
http://dx.doi.org/10.1038/s41375-022-01767-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9898039/
https://www.ncbi.nlm.nih.gov/pubmed/36434065
http://dx.doi.org/10.1038/s41375-022-01767-y

Ejemplares similares